IGC Pharma
IGC
#10700
Rank
C$36.02 M
Marketcap
C$0.35
Share price
1.02%
Change (1 day)
-40.69%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Net assets

Net assets on the balance sheet as of March 2026 : C$8.58 Million

According to IGC Pharma's latest financial reports the company has C$8.58 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

IGC Pharma - Net assets on balance sheet (from 2006 to 2026)

Net assets by year

Year Net assets Change
2025-03-31$C$9.1 M-7.98%
2024-03-31$C$9.89 M-50.93%
2023-03-31$C$20.17 M-32.45%
2022-03-31$C$29.86 M-27.55%
2021-03-31$C$41.21 M10.32%
2020-03-31$C$37.35 M-16.63%
2019-03-31$C$44.8 M330.93%
2018-03-31$C$10.39 M6.3%
2017-03-31$C$9.78 M-46.01%
2016-03-31$C$18.11 M-3.18%
2015-03-31$C$18.71 M19.71%
2014-03-31$C$15.63 M2.65%
2013-03-31$C$15.22 M-3.57%
2012-03-31$C$15.79 M123.34%
2011-03-31$C$7.07 M-73.18%
2010-03-31$C$26.37 M-44.62%
2009-03-31$C$47.62 M14.87%
2008-03-31$C$41.45 M-32.33%
2007-03-31$C$61.26 M3.78%
2006-03-31$C$59.02 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sterling Infrastructure
STRL
C$1.94 B 22,617.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
C$1.60 B 18,617.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
C$1.12 B 13,056.94%๐Ÿ‡บ๐Ÿ‡ธ USA